More documents from Gehring, Thomas; Krapohl, Sebastian

Export to your Reference Manger

Please Copy & Paste



Bookmark and Share

Single market regulation between technocratic independence and political control : the European Agency for the Evaluation of Medicinal Products and the authorisation of pharmaceuticals

[working paper]

Gehring, Thomas; Krapohl, Sebastian

fulltextDownloadDownload full text

(135 KByte)

Citation Suggestion

Please use the following Persistent Identifier (PID) to cite this document:

Further Details
Corporate Editor Bamberger Centrum für Empirische Studien (BACES)
Abstract "The paper explores the successful European scheme for the authorisation of pharmaceuticals within the Single Market. Theoretically, it argues that successful regulation requires the exclusion of parochial interests from the decision process and the strict limitation of the agency's opportunities to adopt arbitrary decisions. Empirically, it holds that these conditions are fulfilled in the European authorisation scheme. The European Agency for the Evaluation of Medicinal Products (EMEA) enjoys a strong agenda-setting power, while it is locked into a control arrangement that precludes arbitrary decisions. Moreover, all actors involved in the decision-making process are bound to a coherent and detailed set of legally binding decision-making criteria as well as subject to judicial review." (author's abstract)
Keywords pharmaceutical; domestic market; steering; decision making
Classification European Politics; Health Policy
Method documentation
Free Keywords Europäische Union
Document language English
Publication Year 2004
City Bamberg
Page/Pages 21 p.
Series BACES Discussion Paper, 4
Licence Deposit Licence - No Redistribution, No Modifications
data provider This metadata entry was indexed by the Special Subject Collection Social Sciences, USB Cologne